105219-37-2

Usage

Uses

Used in Pharmaceutical Industry:
3-(3,5-DIFLUORO-PHENYL)-PROPAN-1-OL is used as a chemical intermediate for the synthesis of pharmaceuticals, contributing to the development of new drugs and medications. Its unique structure allows it to be a key component in the creation of molecules with potential therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical sector, 3-(3,5-DIFLUORO-PHENYL)-PROPAN-1-OL is utilized as an intermediate in the production of agrochemicals, such as pesticides and herbicides. Its role in these compounds can enhance crop protection and contribute to increased agricultural productivity.
Used in Organic Synthesis:
3-(3,5-DIFLUORO-PHENYL)-PROPAN-1-OL is used as a building block in organic synthesis across various industries. Its chemical versatility supports the creation of a broad spectrum of organic molecules for different applications, including but not limited to materials science, specialty chemicals, and research compounds.
Used in Research and Development:
3-(3,5-DIFLUORO-PHENYL)-PROPAN-1-OL is also used in research and development settings for exploring its potential biological activities and pharmaceutical applications. Studies on 3-(3,5-DIFLUORO-PHENYL)-PROPAN-1-OL may lead to the discovery of new treatments for various diseases and conditions.

InChI:InChI=1/C9H10F2O/c10-8-4-7(2-1-3-12)5-9(11)6-8/h4-6,12H,1-3H2

Upstream product

• 79538-22-0 1-allyl-3,5-difluorobenzene 
• 84315-24-2 3-(3,5-difluorophenyl)propionic acid 
• 62351-47-7 3,5-difluorophenylmagnesium bromide 

Downstream Products

• 105219-39-4 3-(3,5-difluorophenyl)propyl azide 
• 1618658-04-0 1-{4-(3,5-difluorophenyl)butyl}-L-arabinoiminofuranose 
• 1618658-00-6 (5S,6S,7S,7aS)-5-{4-(3,5-difluorophenyl)butyl}-6,7-dihydroxytetrahydropyrrolo[1,2-c]oxazol-3(1H)-one 
• 1618657-96-7 (1aR,1bS,6S,6aS)-6-{4-(3,5-difluorophenyl)butyl}tetrahydrooxireno[2',3':3,4]pyrrolo[1,2-c]oxazol-4(1aH)-one 
• 1618657-95-6 (5S,7aR)-5-(4-(3,5-difluorophenyl)butyl)-1,7a-dihydropyrrolo[1,2-c]oxazol-3(5H)-one 
• 1618657-89-8 {3-(3,5-difluorophenyl)propyl}zinc bromide 
• 706815-59-0 (3Z,11Z,16Z)-(5S,6S,7R,8R,9S,13S,14S,15S)-8,14-Bis-(tert-butyl-dimethyl-silanyloxy)-19-(3,5-difluoro-phenyl)-5,7,9,11,13,15-hexamethyl-nonadeca-1,3,11,16-tetraen-6-ol 

Relevant academic research and scientific papers

Synthesis and biological evaluation of α-1-C-4′-arylbutyl-l- arabinoiminofuranoses, a new class of α-glucosidase inhibitors

A series of α-1-C-4′-arylbutyl-l-arabinoiminofuranoses 3 with functional groups attached to the phenyl ring, which are potential α-glycosidase inhibitors, was designed and synthesized by using a Negishi cross-coupling reaction as the key reaction. Arylbut

Design, synthesis and cytotoxicity of 7-deoxy aryl discodermolide analogues

A series of 7-deoxy discodermolide analogues in which the lactone fragment 'C' was replaced by aryl substituents were designed, synthesized, and evaluated for cytotoxicity.

4-Aralkyl-5-substituted-1,2,4-triazole-5-thiols

Compounds of formula (I) and pharmaceutically acceptable salts thereof are described in which, n is 0 to 5; X1 to X5 are any accessible combination of hydrogen, halogen, C1 6alkyl, C1 6alkoxy, cyano, nitro, SONH2, SO2NH2, SO2CH3, SO2CH2F, SO2CHF2, SO2CF3, CF3, CHO, OH, CH2OH, CO2H, or CO2CpH2p+1wherein p is 1 to 4; R1 is phenyl substituted by X1 to X5, C1 4alkyl, C3 6cycloalkyl, or an arylC1 4alkyl group substituted by X1 to X5; R2 is hydrogen, C1 4alkyl or (CH2)m-CO2R3; m is 0 to 5; and R3 is H or C1 4alkyl. These compounds are dopamine-β-hydroxylase inhibitors. Pharmaceutical compositions are described as are methods of use. Processes for the preparation of these compounds are described.

Dopamine-β-hydroxylase inhibitors and use thereof

The compounds of this invention are 1-phenylalkyl-2-mercaptotetrazole compounds which are dopamine-β-hydroxylase inhibitors.